Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multi-site Investigation of Genetic Determinants of Warfarin Dose Variability in Latinos.
El Rouby N, Rodrigues Marcatto L, Claudio K, Camargo Tavares L, Steiner H, Botton MR, Lubitz SA, Fallon EN, Yee K, Kaye J, Scott SA, Karnes J, Caleb Junior de Lima Santos P, Duconge J, Cavallari LH. El Rouby N, et al. Among authors: duconge j. Clin Transl Sci. 2021 Jan;14(1):268-276. doi: 10.1111/cts.12854. Epub 2020 Sep 8. Clin Transl Sci. 2021. PMID: 32860733 Free PMC article.
Prediction of warfarin dose reductions in Puerto Rican patients, based on combinatorial CYP2C9 and VKORC1 genotypes.
Valentin II, Vazquez J, Rivera-Miranda G, Seip RL, Velez M, Kocherla M, Bogaard K, Cruz-Gonzalez I, Cadilla CL, Renta JY, Feliu JF, Ramos AS, Alejandro-Cowan Y, Gorowski K, Ruaño G, Duconge J. Valentin II, et al. Among authors: duconge j. Ann Pharmacother. 2012 Feb;46(2):208-18. doi: 10.1345/aph.1Q190. Epub 2012 Jan 24. Ann Pharmacother. 2012. PMID: 22274142 Free PMC article.
Development of a pharmacogenetic-guided warfarin dosing algorithm for Puerto Rican patients.
Ramos AS, Seip RL, Rivera-Miranda G, Felici-Giovanini ME, Garcia-Berdecia R, Alejandro-Cowan Y, Kocherla M, Cruz I, Feliu JF, Cadilla CL, Renta JY, Gorowski K, Vergara C, Ruaño G, Duconge J. Ramos AS, et al. Among authors: duconge j. Pharmacogenomics. 2012 Dec;13(16):1937-50. doi: 10.2217/pgs.12.171. Pharmacogenomics. 2012. PMID: 23215886 Free PMC article.
Effect of cilostazol on platelet reactivity among patients with peripheral artery disease on clopidogrel therapy.
Hernandez-Suarez DF, Núñez-Medina H, Scott SA, Lopez-Candales A, Wiley JM, Garcia MJ, Melin K, Nieves-Borrero K, Rodriguez-Ruiz C, Marshall L, Duconge J. Hernandez-Suarez DF, et al. Among authors: duconge j. Drug Metab Pers Ther. 2018 Mar 28;33(1):49-55. doi: 10.1515/dmpt-2017-0032. Drug Metab Pers Ther. 2018. PMID: 29408797 Free PMC article. Clinical Trial.
Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean population.
Hernandez-Suarez DF, Botton MR, Scott SA, Tomey MI, Garcia MJ, Wiley J, Villablanca PA, Melin K, Lopez-Candales A, Renta JY, Duconge J. Hernandez-Suarez DF, et al. Among authors: duconge j. Pharmgenomics Pers Med. 2018 Jun 8;11:95-106. doi: 10.2147/PGPM.S165805. eCollection 2018. Pharmgenomics Pers Med. 2018. PMID: 29922082 Free PMC article.
113 results